Skip to main content

Trastuzumab and beyond: New possibilities for the treatment of HER2-positive breast cancer - The Morris/Carey article reviewed

Publication ,  Journal Article
Marcom, PK; Verrier, CS
Published in: ONCOLOGY-NEW YORK
December 1, 2006

Duke Scholars

Published In

ONCOLOGY-NEW YORK

ISSN

0890-9091

Publication Date

December 1, 2006

Volume

20

Issue

14

Start / End Page

1775 / 1776

Publisher

P R R INC
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Marcom, P Kelly, and Carmel S. Verrier. “Trastuzumab and beyond: New possibilities for the treatment of HER2-positive breast cancer - The Morris/Carey article reviewed.” ONCOLOGY-NEW YORK 20, no. 14 (December 1, 2006): 1775–76.
Marcom, P. Kelly, and Carmel S. Verrier. “Trastuzumab and beyond: New possibilities for the treatment of HER2-positive breast cancer - The Morris/Carey article reviewed.” ONCOLOGY-NEW YORK, vol. 20, no. 14, P R R INC, Dec. 2006, pp. 1775–76.
Marcom PK, Verrier CS. Trastuzumab and beyond: New possibilities for the treatment of HER2-positive breast cancer - The Morris/Carey article reviewed. ONCOLOGY-NEW YORK. P R R INC; 2006 Dec 1;20(14):1775–1776.

Published In

ONCOLOGY-NEW YORK

ISSN

0890-9091

Publication Date

December 1, 2006

Volume

20

Issue

14

Start / End Page

1775 / 1776

Publisher

P R R INC